The Biosimilars Forum
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2015 | 1,687,500 | 1,004,889 | 682,611 | 8.2 | 0% |
| 2016 | 1,750,000 | 1,758,702 | −8,702 | 4.6 | 0% |
| 2017 | 1,575,000 | 1,697,902 | −122,902 | 3.9 | 0% |
| 2018 | 1,437,020 | 1,105,993 | 331,027 | 9.6 | 0% |
| 2019 | 1,777,994 | 2,050,112 | −272,118 | 3.6 | 0% |
| 2020 | 2,242,189 | 1,952,658 | 289,531 | 5.5 | 0% |
| 2021 | 2,082,865 | 2,279,654 | −196,789 | 3.7 | 0% |
| 2022 | 2,105,000 | 2,419,221 | −314,221 | 1.9 | 0% |
| 2023 | 2,280,500 | 2,430,491 | −149,991 | 1.2 | 0% |
In its most recent public year (2023), this organization spent $149,991 more than it brought in. Its reserves stood at about 1.2 months of spending, down from 8.2 in 2015. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works